Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein
about
Beta-trace gene expression is regulated by a core promoter and a distal thyroid hormone response elementDetection of gene annotations and protein-protein interaction associated disorders through transitive relationships between integrated annotationsTranscriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters.The third IGF-II promoter specifies transcription of three transcripts out of five in human placenta.A conserved structural element in horse and mouse IGF2 genes binds a methylation sensitive factorKinetics and regulation of site-specific endonucleolytic cleavage of human IGF-II mRNAs.Wilms tumor genetics.Insulin-like growth factors I and II.Promoter-specific expression and imprint status of marsupial IGF2Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequencesA systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P3 and IGF2-P4 regulatory sequences.Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencingAutonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment.Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathwaysTissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesisThe retinoblastoma gene product regulates Sp1-mediated transcriptionStructure, evolution, expression and regulation of insulin-like growth factors I and II.Transcription factor ZBED6 mediates IGF2 gene expression by regulating promoter activity and DNA methylation in myoblasts.Molecular biology of the insulin-like growth factors. Relevance to nervous system function.Polypeptide growth factors and the kidney: a developmental perspective.The liver-specific promoter of the human insulin-like growth factor II gene is activated by CCAAT/enhancer binding protein (C/EBP).Identification of RNA sequences and structures involved in site-specific cleavage of IGF-II mRNAs.Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.Long-range RNA interaction of two sequence elements required for endonucleolytic cleavage of human insulin-like growth factor II mRNAs.Transactivation of mouse insulin-like growth factor II (IGF-II) gene promoters by the AP-1 complex.Wilms' tumor: a paradigm for insights into development and cancer.Site-specific cleavage of IGF-II mRNAs requires sequence elements from two distinct regions of the IGF-II gene.Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms.Gene imprinting during placental and embryonic development.Insulin-like growth factor II in two human colon-carcinoma cell lines: gene structure and expression, and protein secretion.Structural analysis of the human insulin-like growth factor-II P3 promoter.Characterisation of the methylation pattern in the intragenic CpG island of the IGF2 gene in Bos taurus indicus cumulus cells during in vitro maturation.Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences.Translation initiation on the insulin-like growth factor II leader 1 is developmentally regulated.Identification of a key regulatory element for the basal activity of the human insulin-like growth factor II gene promoter P3.Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.Identification and expression analysis of cDNA encoding insulin-like growth factor 2 in horses.Monoalleleic transcription of the insulin-like growth factor-II gene (Igf2) in chick embryos.
P2860
Q28238980-923049D1-FBA3-4555-A67C-02700BE48B0BQ28643974-5BB07B19-1E57-4AD9-A6E6-BB6D5AC89F60Q30467807-02A4551C-18BC-49DB-ADC9-FDFE3F9C6D6FQ31147342-D4E3C0E8-6987-47AF-8235-341FEDCA2D46Q32085871-CEA40905-CF40-424C-B5A4-C0202F1015D4Q33941792-D29F856D-166C-45F1-AD7A-CD9B053A110BQ34067724-6A4AB82A-D82C-4E51-8506-C5E2296D2177Q34221300-3539324B-166D-4DB5-99E0-01C18A4F1DA2Q34358824-CEF00183-411F-4027-BE24-23B7D7215878Q34467904-7F94B67F-0573-4E86-AAF0-1ABE348C0356Q34568722-60C3ECAA-9990-494D-9D08-3EB24FFF98A6Q35040696-4209FF52-AE6B-41C0-A2E6-678A20C72BC4Q35194293-65D04729-6246-41BD-8F80-01C51BF1BBA7Q35814194-5AA7A63E-3ECD-4519-8649-601DE1E48645Q36104060-8D9F9231-22D2-4262-81F7-6AB7314CBDBEQ36691084-575D99B5-FE16-4753-A144-10F71D2239D1Q36700830-1BAE094C-F0FB-4675-9B68-BB77C1FF13ECQ36816438-19F54C3E-C7F6-4ABF-84AA-CF5F7ECEE02CQ36922028-A88D29C4-4BE7-488B-B8D8-FD532B132693Q37678936-5DE39429-6B60-42BA-B57C-3939B9CA8FF2Q37782846-498072F9-63BD-48A6-95AE-0DBAB4319B56Q37954175-C5683B07-723F-4F1B-81BC-9636D459C7A8Q38328045-3069E349-D429-4CD6-9766-CAD105775F82Q38330563-C11E3FB7-0653-46B6-9985-8B271BD254E9Q39034561-72A4ED2C-A757-4158-B307-BBFC638739E3Q40021441-7735959F-15B4-47DE-8B91-431A33AA3E79Q40406568-DBA6AF86-E04A-4B62-97C1-D48EFE73F6C7Q40456138-EF92F168-7E62-44D1-BD64-F698F076861EQ40534497-6E427832-3DFE-4067-BE85-8B3BAB7004E2Q40735954-73BB2D90-B183-4946-9797-3596D41C033CQ40803192-43C45927-7DF8-4DC2-8DA0-115FBCC53652Q41602578-9F650D53-A9C2-4879-9CAB-DA6F0D8E07A2Q41844735-3CE89D06-99F9-4526-810A-FA67C3898462Q41904366-3B9031EB-505D-44DE-AD3C-431EEF2F6B13Q42012571-E9E2738A-6D60-4BB4-BD0F-5959508E743EQ42095988-7E2033A8-904B-4E6D-AF75-8C7B4C5DC807Q42454924-560C9DAF-0798-4CDF-BFF9-57618C484AD5Q45770049-43FF901E-2D9C-4C38-87F6-A00D81C9D64AQ46259020-8FEC2C46-F5B2-4880-ABBD-AE427D6A8B25Q47851124-5CAEA272-FA39-4E89-8533-5F2C15CD3FA8
P2860
Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein
description
1988 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1988
@ast
im September 1988 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1988/09/07)
@sk
vědecký článek publikovaný v roce 1988
@cs
wetenschappelijk artikel (gepubliceerd op 1988/09/07)
@nl
наукова стаття, опублікована у вересні 1988
@uk
مقالة علمية (نشرت في 7-9-1988)
@ar
name
Differential expression of the ...... tive IGF-II-associated protein
@ast
Differential expression of the ...... tive IGF-II-associated protein
@en
Differential expression of the ...... tive IGF-II-associated protein
@nl
type
label
Differential expression of the ...... tive IGF-II-associated protein
@ast
Differential expression of the ...... tive IGF-II-associated protein
@en
Differential expression of the ...... tive IGF-II-associated protein
@nl
prefLabel
Differential expression of the ...... tive IGF-II-associated protein
@ast
Differential expression of the ...... tive IGF-II-associated protein
@en
Differential expression of the ...... tive IGF-II-associated protein
@nl
P2093
P1476
Differential expression of the ...... tive IGF-II-associated protein
@en
P2093
F. M. van Schaik
J. S. Sussenbach
P. de Pagter-Holthuizen
R. A. van der Kammen
P304
P356
10.1016/0167-4781(88)90124-8
P407
P577
1988-09-07T00:00:00Z